Abstract
Cardiovascular complications are common in fibrosing alveolitis, but there have been few physiological studies of the pulmonary circulation in this condition, and those that have been carried out have usually depended on right heart catheterisation. This paper reports non-invasive measurements of effective pulmonary blood flow, oxygen uptake, pulmonary arteriovenous oxygen content differences, and estimates of mixed venous oxygen saturation in 20 patients with histologically proved cryptogenic fibrosing alveolitis at rest and while exercising on a motorized treadmill. Results were compared with those of 20 age and sex matched normal subjects, at rest and at an arbitrarily chosen oxygen uptake of 0.75 l/min. The latter results were obtained by linear interpolation. Effective pulmonary blood flow was normal at rest, but oxygen dispatch to the tissues (blood flow x blood oxygen content) was significantly reduced at rest (mean reduction 190 (SD 68) ml/l/min; p less than 0.01) and at an oxygen uptake of 0.75 l/min (mean reduction 128 (50) ml/l/min; p less than 0.02), reflecting the presence of systemic arterial hypoxaemia. Pulmonary arteriovenous oxygen content differences were similar in patients and normal subjects, but mixed venous saturation was lower in the patients at rest (mean % reduction 6.8 (2.6); p less than 0.02) and at an oxygen uptake of 0.75 l/min (mean % reduction 9.6 (2.9); p less than 0.002). It is concluded that the supply of oxygen potentially available to the tissues is reduced at rest and during exercise in patients with fibrosing alveolitis and hence, by analogy with normal people exercising under hypoxic conditions, that pulmonary blood flow is inappropriately low in this condition. The low mixed venous oxygen saturation may contribute to the development of pulmonary hypertension in some patients. The rebreathing technique used in this study may be of use in monitoring treatment; it could be applied many times to the same patient, and might be a suitable way of following the response to pulmonary vasodilators.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ASMUSSEN E., NIELSEN M. The cardiac output in rest and work at low and high oxygen pressures. Acta Physiol Scand. 1955 Dec 22;35(1):73–83. doi: 10.1111/j.1748-1716.1955.tb01266.x. [DOI] [PubMed] [Google Scholar]
- ASTRAND P. O., CUDDY T. E., SALTIN B., STENBERG J. CARDIAC OUTPUT DURING SUBMAXIMAL AND MAXIMAL WORK. J Appl Physiol. 1964 Mar;19:268–274. doi: 10.1152/jappl.1964.19.2.268. [DOI] [PubMed] [Google Scholar]
- AUSTRIAN R., McCLEMENT J. H., RENZETTI A. D., Jr, DONALD K. W., RILEY R. L., COURNAND A. Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion; the syndrome of "alveolar-capillary block". Am J Med. 1951 Dec;11(6):667–685. doi: 10.1016/0002-9343(51)90019-8. [DOI] [PubMed] [Google Scholar]
- Bruce R. A. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res. 1971 Dec;3(6):323–332. [PubMed] [Google Scholar]
- Burdon J. G., Killian K. J., Jones N. L. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax. 1983 Oct;38(10):778–784. doi: 10.1136/thx.38.10.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bush A., Busst C. M., Johnson S., Denison D. M. Rebreathing method for the simultaneous measurement of oxygen consumption and effective pulmonary blood flow during exercise. Thorax. 1988 Apr;43(4):268–275. doi: 10.1136/thx.43.4.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bye P. T., Anderson S. D., Woolcock A. J., Young I. H., Alison J. A. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis. 1982 Dec;126(6):1005–1012. doi: 10.1164/arrd.1982.126.6.1005. [DOI] [PubMed] [Google Scholar]
- Davidson F. F., Glazier J. B., Murray J. F. The components of the alveolar-arterial oxygen tension difference in normal subjects and in patients with pneumonia and obstructive lung disease. Am J Med. 1972 Jun;52(6):754–762. doi: 10.1016/0002-9343(72)90081-2. [DOI] [PubMed] [Google Scholar]
- Davies N. J., Denison D. M. The measurement of metabolic gas exchange and minute volume by mass spectrometry alone. Respir Physiol. 1979 Feb;36(2):261–267. doi: 10.1016/0034-5687(79)90029-x. [DOI] [PubMed] [Google Scholar]
- FINLEY T. N., SWENSON E. W., COMROE J. H., Jr The cause of arterial hypoxemia at rest in patients with "alveolarcapillary block syndrome". J Clin Invest. 1962 Mar;41:618–622. doi: 10.1172/JCI104517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fulmer J. D., Roberts W. C., von Gal E. R., Crystal R. G. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest. 1979 Apr;63(4):665–676. doi: 10.1172/JCI109349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
- Gibson G. J., Pride N. B. Pulmonary mechanics in fibrosing alveolitis: the effects of lung shrinkage. Am Rev Respir Dis. 1977 Oct;116(4):637–647. doi: 10.1164/arrd.1977.116.4.637. [DOI] [PubMed] [Google Scholar]
- Gillett D. S., Gunning K. E., Sawicka E. H., Bellingham A. J., Ware R. J. Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation. Br Med J (Clin Res Ed) 1987 Jan 10;294(6564):81–82. doi: 10.1136/bmj.294.6564.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawrylkiewicz I., Izdebska-Makosa Z., Grebska E., Zielinski J. Pulmonary haemodynamics at rest and on exercise in patients with idiopathic pulmonary fibrosis. Bull Eur Physiopathol Respir. 1982 May-Jun;18(3):403–410. [PubMed] [Google Scholar]
- Lupi-Herrera E., Seoane M., Verdejo J., Gomez A., Sandoval J., Barrios R., Martinez W. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. Chest. 1985 May;87(5):564–573. doi: 10.1378/chest.87.5.564. [DOI] [PubMed] [Google Scholar]
- McCarthy D., Cherniack R. M. Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1973 Feb;107(2):200–208. doi: 10.1164/arrd.1973.107.2.200. [DOI] [PubMed] [Google Scholar]
- Miller W. C., Heard J. G., Unger K. M., Suich D. M. Anatomical lung shunting in pulmonary fibrosis. Thorax. 1986 Mar;41(3):208–209. doi: 10.1136/thx.41.3.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PUGH L. G., GILL M. B., LAHIRI S., MILLEDGE J. S., WARD M. P., WEST J. B. MUSCULAR EXERCISE AT GREAT ALTITUDES. J Appl Physiol. 1964 May;19:431–440. doi: 10.1152/jappl.1964.19.3.431. [DOI] [PubMed] [Google Scholar]
- Petrini M. F., Peterson B. T., Hyde R. W. Lung tissue volume and blood flow by rebreathing theory. J Appl Physiol Respir Environ Exerc Physiol. 1978 May;44(5):795–802. doi: 10.1152/jappl.1978.44.5.795. [DOI] [PubMed] [Google Scholar]
- Tukiainen P., Taskinen E., Holsti P., Korhola O., Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax. 1983 May;38(5):349–355. doi: 10.1136/thx.38.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner P. D., Dantzker D. R., Dueck R., de Polo J. L., Wasserman K., West J. B. Distribution of ventilation-perfusion ratios in patients with interstitial lung disease. Chest. 1976 Feb;69(2 Suppl):256–257. doi: 10.1378/chest.69.2_supplement.256-a. [DOI] [PubMed] [Google Scholar]
- Widimsky J., Riedel M., Stanek V. Central haemodynamics during exercise in patients with restrictive pulmonary disease. Bull Eur Physiopathol Respir. 1977 May-Jun;13(3):369–379. [PubMed] [Google Scholar]
